New hormone protocol cut relapse risk in prostate cancer trial
Angus reports on the basic research, clinical science, and drug development that may transform survival and quality of…
Revolution Medicines starts early access for pancreatic cancer drug
Adam Feuerstein is a senior writer and biotech columnist, reporting on the crossroads of drug development, business, Wall…